Liquidizing FUS via prion-like domain phosphorylation.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

14 citing papers in PubMed.

1. Sensing and Filtering Environmental Fluctuations: The Case of Biomolecular Condensates in Plants.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
   Review
2. Design and applications of synthetic biomolecular condensates.Nature nanotechnology · 2026
   Review
3. Abl kinase-mediated FUS Tyr526 phosphorylation alters nucleocytoplasmic FUS localization in FTLD-FUS.Brain : a journal of neurology · 2023
   Article
4. Saccharomyces cerevisiae as a research tool for RNA-mediated human disease.Wiley interdisciplinary reviews. RNA · 2023
   Review
5. Stress Granules as Causes and Consequences of Translation Suppression.Antioxidants & redox signaling · 2023
   Review
6. TheActa biochimica et biophysica Sinica · 2023
   Article
7. Post-translational modifications in liquid-liquid phase separation: a comprehensive review.Molecular biomedicine · 2022
   Review
8. Liquid-to-solid phase transition of oskar ribonucleoprotein granules is essential for their function in Drosophila embryonic development.Cell · 2022
   Article
9. Post-Translational Modifications Modulate Proteinopathies of TDP-43, FUS and hnRNP-A/B in Amyotrophic Lateral Sclerosis.Frontiers in molecular biosciences · 2021
   Review
10. The multifaceted role of kinases in amyotrophic lateral sclerosis: genetic, pathological and therapeutic implications.Brain : a journal of neurology · 2020
    Review
11. The molecular language of membraneless organelles.The Journal of biological chemistry · 2019
    Review
12. Therapeutic Dissolution of Aberrant Phases by Nuclear-Import Receptors.Trends in cell biology · 2019
    Review
13. Amyloid assembly and disassembly.Journal of cell science · 2018
    Review
14. Environment-transformable sequence-structure relationship: a general mechanism for proteotoxicity.Biophysical reviews · 2018
    Review

Corrections and comments

• Comment on
  Phosphorylation of the FUS low-complexity domain disrupts phase separation, aggregation, and toxicity.2017

Authors and funding

1 author.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as